Literature DB >> 22864815

A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7.

Chen Wang1, Chao Gao, Jun-Long Zhuang, Chao Ding, Yong Wang.   

Abstract

BACKGROUND AND AIMS: MicroRNAs (miRNAs) are short noncoding RNAs that regulate gene expression by targeting mRNAs. Our previous study found that miR-29b strongly regulates the migration and invasion of breast cancer cells. Here, we aimed to identify the mRNAs targeted by miR-29b.
METHODS: We used microarray experiments in conjunction with computational methods to identify the mRNAs that were most susceptible to miR-29b-mediated repression. We further confirmed the activities of three target genes, C1QTNF6, SPARC, and COL4A2, by luciferase reporter analyses and invasion assays.
RESULTS: We evaluated the impact of miR-29b on global mRNA expression in MCF-7 human breast cancer cells through microarray analysis and further analyzed four genes that were at least twofold down-regulated and predicted as miR-29b targets by at least two of the four widely used miRNA target prediction algorithms. We also analyzed one mRNA that was down-regulated by 1.8-fold but was predicted to have significant interactions with miR-29b in pathway analysis and was predicted as a miR-29b target by all four algorithms. Luciferase reporter and invasion assays revealed that C1QTNF6, SPARC, and COL4A2 were targeted by miR-29b and that the degradation of any one of these mRNAs could promote invasion in MCF-7 cells.
CONCLUSIONS: C1QTNF6, SPARC, and COL4A2 are targeted by miR-29b, and the down-regulation of these three mRNAs can contribute to the invasion ability of MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22864815     DOI: 10.1007/s00432-012-1288-x

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  27 in total

1.  Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells.

Authors:  Pedro Cortes-Reynosa; Teresa Robledo; Marina Macias-Silva; S Vincent Wu; Eduardo Perez Salazar
Journal:  Matrix Biol       Date:  2007-11-12       Impact factor: 11.583

2.  MicroRNAs direct rapid deadenylation of mRNA.

Authors:  Ligang Wu; Jihua Fan; Joel G Belasco
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-22       Impact factor: 11.205

3.  Cell-type-specific signatures of microRNAs on target mRNA expression.

Authors:  Pranidhi Sood; Azra Krek; Mihaela Zavolan; Giuseppe Macino; Nikolaus Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

4.  Suppression of type I collagen production by microRNA-29b in cultured human stellate cells.

Authors:  Tomohiro Ogawa; Masashi Iizuka; Yumiko Sekiya; Katsutoshi Yoshizato; Kazuo Ikeda; Norifumi Kawada
Journal:  Biochem Biophys Res Commun       Date:  2009-11-12       Impact factor: 3.575

5.  miR-29b regulates migration of human breast cancer cells.

Authors:  Chen Wang; Zhen Bian; Da Wei; Jian-guo Zhang
Journal:  Mol Cell Biochem       Date:  2011-02-26       Impact factor: 3.396

6.  MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells.

Authors:  Robert Steele; Justin L Mott; Ratna B Ray
Journal:  Genes Cancer       Date:  2010-04-01

7.  Expression of a secretory protein C1qTNF6, a C1qTNF family member, in hepatocellular carcinoma.

Authors:  Tamotsu Takeuchi; Yoshihiro Adachi; Tomoko Nagayama
Journal:  Anal Cell Pathol (Amst)       Date:  2011       Impact factor: 2.916

8.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

9.  Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies.

Authors:  Michael D Mattie; Christopher C Benz; Jessica Bowers; Kelly Sensinger; Linda Wong; Gary K Scott; Vita Fedele; David Ginzinger; Robert Getts; Chris Haqq
Journal:  Mol Cancer       Date:  2006-06-19       Impact factor: 27.401

10.  Role of miR-29b on the regulation of the extracellular matrix in human trabecular meshwork cells under chronic oxidative stress.

Authors:  Coralia Luna; Guorong Li; Jianmimg Qiu; David L Epstein; Pedro Gonzalez
Journal:  Mol Vis       Date:  2009-11-28       Impact factor: 2.367

View more
  15 in total

1.  Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ).

Authors:  Heng-Jia Liu; Hilaire C Lam; Christian V Baglini; Julie Nijmeh; Alischer A Cottrill; Stephen Y Chan; Elizabeth P Henske
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

Review 2.  Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.

Authors:  Thomas Klonisch; Aleksandra Glogowska; Thatchawan Thanasupawat; Maxwell Burg; Jerry Krcek; Marshall Pitz; Appalaraju Jaggupilli; Prashen Chelikani; G William Wong; Sabine Hombach-Klonisch
Journal:  Br J Pharmacol       Date:  2016-08-11       Impact factor: 8.739

3.  MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR.

Authors:  Yue Wang; Ming Cui; Bao-di Sun; Fa-bao Liu; Xiao-dong Zhang; Li-hong Ye
Journal:  Acta Pharmacol Sin       Date:  2014-08-04       Impact factor: 6.150

4.  Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis.

Authors:  Qiao-Hui Chen; Qing-Bing Wang; Bei Zhang
Journal:  Tumour Biol       Date:  2013-08-29

5.  An adiponectin paralog protein, CTRP6 decreased the proliferation and invasion activity of oral squamous cell carcinoma cells: possible interaction with laminin receptor pathway.

Authors:  Kimika Hano; Kiichi Hatano; Chiemi Saigo; Yusuke Kito; Toshiyuki Shibata; Tamotsu Takeuchi
Journal:  Mol Biol Rep       Date:  2019-06-28       Impact factor: 2.316

Review 6.  miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.

Authors:  Nicola Amodio; Marco Rossi; Lavinia Raimondi; Maria Rita Pitari; Cirino Botta; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Oncotarget       Date:  2015-05-30

7.  hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC.

Authors:  Shitong Zhang; Jianjun Jin; Xiaoxiao Tian; Lijuan Wu
Journal:  Oncotarget       Date:  2017-11-10

8.  MicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients ≤35 years.

Authors:  Elen Pereira Bastos; Helena Brentani; Fatima Solange Pasini; Aderbal Ruy T Silva; Cesar Henrique Torres; Renato David Puga; Eloisa Helena Ribeiro Olivieri; Amanda Rusiska Piovezani; Carlos Alberto de Bragança Pereira; Ariane Machado-Lima; Dirce Maria Carraro; Maria Mitzi Brentani
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

Review 9.  The role of miR-29b in cancer: regulation, function, and signaling.

Authors:  Bin Yan; Qiong Guo; Fa-Jun Fu; Zhao Wang; Zhuo Yin; Yong-Bao Wei; Jin-Rui Yang
Journal:  Onco Targets Ther       Date:  2015-03-03       Impact factor: 4.147

10.  Bioinformatics Analysis of Choriocarcinoma-Related MicroRNA-Transcription Factor-Target Gene Regulatory Networks and Validation of Key miRNAs.

Authors:  Xiaotong Peng; Zhirong Zhang; Yanqun Mo; Junliang Liu; Shuo Wang; Huining Liu
Journal:  Onco Targets Ther       Date:  2021-06-29       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.